Read about our latest research, initiatives, announcements, and other news.
In March 2018, the Health Care Price Index rose by 2.2% compared to the previous year, fractionally higher than in February, and the highest rate since January 2012. Driving overall price acceleration is high hospital price growth of 3.7%, barely down from 3.8% in February—a more than 8-year high.
Altarum's latest Health Sector Economic Indicators provide a second look at spending for the entire 2017 calendar year and suggest that national health spending grew by 4.6% from its 2016 level.
CMS just released an extensive evaluation of the Community-based Care Transitions Program. Unfortunately, the primary metrics used to measure performance—re-hospitalization/discharge rates—are not always good for patients. We should also include how communities and their social support organizations can improve access to adequate safe housing, nutritious food, reliable personal care, and other key services.
The cost of the country’s opioid crisis is estimated to have exceeded $1 trillion from 2001 to 2017, and is projected to cost an additional $500 billion by 2020, according to analysis released today by Altarum, a nonprofit health research and consulting institute.
National health spending rose 4.7 percent in 2017, slightly above GDP, but keeping its share of GDP at 18 percent, according to Altarum’s latest Health Sector Economic Indicators Briefs.
Altarum announces MIPScast™, a user-friendly, interactive web-based tool designed to help clinicians predict and improve their Merit-based Incentive Payment System (MIPS) scores in order to comply with the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
U.S. health sector spending continues to grow at a more sustainable rate, driven in part by a slowdown in hiring, hospital spending, and price growth in hospitals, physician and clinical services, and prescription drugs, according to Altarum’s latest Health Sector Economic Indicators briefs.
The rate at which children die in the first year of life—a basic measure of population health—has declined in the U.S. over the past decade, but remains higher than peer nations, and varies dramatically for populations across the country.